Chasing Value in a Changing World A new report from PharmaFutures explains how the industry may move forward to combine business imperatives and social mandates through new strategies for determining value and reimbursement for medicines. The study determines that collaboration across three fronts is needed to ensure that value is recognized and adapted over time ...Read more
2013: Unlocking the Key to Public Funding in Brazil The Brazilian Ministry of Health recently announced plans to spend $17 billion on drugs between 2013 and 2016. Significantly, 40 percent of current federal spending on drugs is on innovative biologics. This not a race-to-the-bottom pool comprised exclusively of cheap generics. For this reason alone, the actions of the government on this new strategic approach to health technology assessment should be followed closely in the industry Csuite ... Read more
Clinical Trials: The Future is Here There has been a drastic shift in clinical trial IT that is forcing biopharmaceutical enterprises to rethink they we conduct clinical trials more efficiently. Moe Alsumidaie looks at some of the new technology that is breaking new ground in the field ... Read more
Why Social Media Won't Replace Pharma Meetings Speaker-led events are a long-established way for people to learn and share ideas. Big Pharma and upstart social media agencies may be at the opposite end of the evolutionary scale of business, but they definitely have one thing in common — massive, rapid change — and in times of disruption, learning is everything, writes Peter Houston ... Read more
Products/Services Profiles
Sciformix
SciVigilance – Pharmacovigilance in a box
SciVigilance provides the powerful combination of streamlined processes, domain expertise and robust technology that integrates disparate data and enables the seamless flow, collection processing and analysis of data. SciVigilance delivers significant time and cost savings, efficiency and compliance gains, all while delivering the highest quality outcomes. Read More
